首页> 外文会议>MEDINFO >Classifier-Free, Integrated Genomic Predictions of Prostate Cancer Recurrence
【24h】

Classifier-Free, Integrated Genomic Predictions of Prostate Cancer Recurrence

机译:自由分类,综合基因组预测前列腺癌复发

获取原文

摘要

Genomic predictions of clinical outcome are a core promise of the Human Genome Project. Yet actionable biomarkers in clinical medicine are confounded by patient heterogeneity as patient phenotypes are rarely well characterized and often poorly understood. Furthermore, standard predictive algorithms rely on a priori knowledge of discrete phenotypes for feature selection and training. To address this limitation, we develop a classifier-free algorithm that matches individual patients to other patient outcomes based on optimized clinicopathologic feature integration and molecular pathway similarity using the K-nearest neighbor. By identifying the best matches within the collection of patient data, we are able to return the desired prediction. In prostate cancer, we demonstrate the algorithm's ability to predict cancer recurrence without the need for supervised learning techniques in independent datasets with a recall and precision of 78%. Importantly, the predictor is microarray platform independent, scalable and simple to implement. Taken together, this method provides an exciting foundation from data-driven, clinical decision-making may arise.
机译:临床结果的基因组预测是人类基因组项目的核心承诺。然而,临床医学中的可行的生物标志物被患者的异质性混淆,因为患者表型很少表征并往往是较差的理解。此外,标准预测算法依赖于特征选择和培训的离散表型的先验知识。为了解决这些限制,我们开发了一种自由分类算法,该分类算法将个体患者与使用K最近邻居的优化的临床病理特征集成和分子途径相似性。通过识别患者数据集合中的最佳匹配,我们能够返回所需的预测。在前列腺癌中,我们展示了算法预测癌症复发的能力,而无需监督独立数据集中的监督学习技术,召回和精确度为78%。重要的是,预测器是微阵列平台独立,可扩展且易于实现。在一起,该方法提供了令人兴奋的基础,从数据驱动,可能会出现临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号